Pro-Dex (NASDAQ:PDEX) Share Price Crosses Below 200 Day Moving Average - Should You Sell?

Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $45.25 and traded as low as $24.04. Pro-Dex shares last traded at $25.35, with a volume of 141,970 shares.

Wall Street Analyst Weigh In

Several equities analysts recently commented on PDEX shares. Wall Street Zen downgraded Pro-Dex from a "buy" rating to a "hold" rating in a research note on Saturday, August 16th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Pro-Dex in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $56.00.

Pro-Dex Price Performance

The business's fifty day simple moving average is $38.62 and its 200-day simple moving average is $45.25. The company has a current ratio of 3.23, a quick ratio of 1.71 and a debt-to-equity ratio of 0.25. The firm has a market cap of $83.15 million, a P/E ratio of 9.39 and a beta of -0.11.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last issued its earnings results on Thursday, September 4th. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.11). Pro-Dex had a net margin of 13.48% and a return on equity of 26.67%. The business had revenue of $17.49 million for the quarter, compared to the consensus estimate of $17.90 million. As a group, analysts forecast that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.

Institutional Investors Weigh In On Pro-Dex

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. American Century Companies Inc. raised its holdings in Pro-Dex by 3.0% during the 1st quarter. American Century Companies Inc. now owns 12,301 shares of the medical instruments supplier's stock valued at $610,000 after acquiring an additional 355 shares during the period. Police & Firemen s Retirement System of New Jersey bought a new position in shares of Pro-Dex in the second quarter worth $28,000. Bank of America Corp DE increased its holdings in shares of Pro-Dex by 173.3% in the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier's stock worth $74,000 after purchasing an additional 1,073 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Pro-Dex in the second quarter worth $50,000. Finally, Osaic Holdings Inc. increased its holdings in shares of Pro-Dex by 23.6% in the second quarter. Osaic Holdings Inc. now owns 7,120 shares of the medical instruments supplier's stock worth $311,000 after purchasing an additional 1,360 shares during the period. Institutional investors own 15.28% of the company's stock.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.